|
業務類別
|
-- |
|
業務概覽
|
Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. Ritonavir tablets, GANOVO, and ASCLEVIR. It also has other drug candidates in its pipeline in their different stages of development such as ASC22, ASC10, ASC11, and ASC40 among others. Geographically, it operates in Mainland China and other regions. |
| 公司地址
| 198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200 |
| 電話號碼
| +86 18106509129 |
| 傳真號碼
| +86 57185389730 |
| 公司網頁
| https://www.ascletis.com |
| 員工數量
| 231 |
| Dr. Jinzi Jason Wu |
Chairman of the Board and Chief Executive Officer |
-- |
25/04/2023 |
| Ms. Judy Hejingdao WU |
Director and Senior Vice President, Operations |
-- |
25/04/2023 |
|
|
| Mr. Jiong Gu |
Independent Director |
25/04/2023 |
| Dr. Jinzi Jason Wu |
Chairman of the Board and Chief Executive Officer |
25/04/2023 |
| Ms. Judy Hejingdao WU |
Director and Senior Vice President, Operations |
25/04/2023 |
| Dr. Yizhen WEI |
Independent Director |
25/04/2023 |
| Ms. Lin HUA |
Independent Director |
25/04/2023 |
|
|
|
|
